5 recent highlights in IBD

Recently published studies have demonstrated new developments in ulcerative colitis and Crohn’s disease.
In case you missed it, the editors of Healio Gastroenterology and Liver Disease have compiled a recap of some of our most recent popular articles involving inflammatory bowel disease, including an FDA Boxed Warning.
FDA approves boxed warning for Xeljanz in UC
The FDA recently issued a safety alert and approved new Boxed Warning for the 10-mg, twice-daily dosage of Xeljanz in patients with ulcerative colitis; the warning comes after increased blood clot and death risks were seen in a

Source link

Related posts

Study tracks milestones in the history of human disease genetics


Anti-TNF Tx Tied to Lower Risk of Arterial Events in IBD


New Therapeutic Hope for Kids with T2D


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy